Inhalation and Nasal Spray Generic Drugs Market Will Exhibit a 5.5% CAGR Till 2023
Regional markets such as Asia Pacific and Latin America show immense growth promise for generic drugs owing to the cost-conscious consumer base. However, these regions present immense challenge for new companies owing to the presence of a large number of local and regional players. Nevertheless, strategic collaborations could enable international companies to establish their businesses. TMR estimates that the global inhalation and nasal spray generic drugs market will exhibit a 5.5% CAGR over the period between 2015 and 2023, rising...
View full press release